Organogenesis (ORGO) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free ORGO Stock Alerts $2.75 +0.02 (+0.73%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12, 2024 | finance.yahoo.comOrganogenesis Holdings First Quarter 2024 Earnings: Beats ExpectationsMay 10, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...May 10, 2024 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPSOrganogenesis (NASDAQ:ORGO - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.01. Organogenesis had a return on equity of 1.81% and a net margin of 1.14%. The business had revenue of $109.98 million during the quarter, compared to the consensus estimate of $100.44 million. During the same quarter last year, the firm posted ($0.02) EPS.May 10, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call TranscriptMay 9, 2024 | fool.comOrganogenesis (ORGO) Q1 2024 Earnings Call TranscriptMay 3, 2024 | markets.businessinsider.comBuy Rating on ORGO: Promising ReNu Trial Results and Significant Market OpportunityMay 3, 2024 | nasdaq.comOrganogenesis Holdings Inc. Class A Common Stock (ORGO)May 2, 2024 | globenewswire.comOrganogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisApril 16, 2024 | globenewswire.comOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024April 3, 2024 | globenewswire.comOrganogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseMarch 19, 2024 | markets.businessinsider.comBuy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market DynamicsMarch 7, 2024 | barrons.comOrganogenesis Holdings Inc. Cl AMarch 6, 2024 | marketbeat.comFY2024 EPS Estimates for Organogenesis Holdings Inc. (NASDAQ:ORGO) Decreased by AnalystOrganogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Organogenesis in a research note issued to investors on Monday, March 4th. Cantor Fitzgerald analyst R. Osborn now forecasts that the cMarch 2, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call TranscriptMarch 2, 2024 | finance.yahoo.comOrganogenesis Holdings Full Year 2023 Earnings: Misses ExpectationsMarch 1, 2024 | fool.comWhy Organogenesis Holding Stock Plummeted by 18% TodayMarch 1, 2024 | marketbeat.comOrganogenesis' (ORGO) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and issued a $5.00 price objective on shares of Organogenesis in a research report on Friday.March 1, 2024 | marketbeat.comTrading was temporarily halted for "ORGO" at 09:03 AM with a stated reason of "LULD pause." Trading set to resume at 09:03 AM. March 1, 2024 | msn.comOrganogenesis (ORGO) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | benzinga.comRecap: Organogenesis Hldgs Q4 EarningsFebruary 29, 2024 | finance.yahoo.comOrganogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024February 29, 2024 | globenewswire.comOrganogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceFebruary 28, 2024 | benzinga.comA Preview Of Organogenesis Hldgs's EarningsFebruary 23, 2024 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Acadian Asset Management LLCAcadian Asset Management LLC increased its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 26.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,590,244 shares of the company'sFebruary 15, 2024 | money.usnews.comOrganogenesis Holdings Inc - Ordinary Shares - Class AFebruary 12, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceFebruary 9, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Organogenesis Holdings Inc.'s FY2023 Earnings (NASDAQ:ORGO)Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2023 earnings estimates for Organogenesis in a research report issued on Wednesday, February 7th. Cantor Fitzgerald analyst R. Osborn anticipates that the company will post earFebruary 8, 2024 | msn.comCantor starts Organogenesis at overweight, cites differentiated portfolioFebruary 8, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024February 7, 2024 | marketbeat.comCantor Fitzgerald Initiates Coverage on Organogenesis (NASDAQ:ORGO)Cantor Fitzgerald started coverage on Organogenesis in a research note on Wednesday. They issued an "overweight" rating and a $5.00 price objective on the stock.February 4, 2024 | marketbeat.comThompson Siegel & Walmsley LLC Purchases 338,448 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Thompson Siegel & Walmsley LLC boosted its position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 284.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 457,400 shares of the company's stock after acquiring anFebruary 2, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 393,523 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Assenagon Asset Management S.A. lowered its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 28.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 971,674 shares of the company's stock after selling 393,January 31, 2024 | marketbeat.comLos Angeles Capital Management LLC Sells 145,952 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Los Angeles Capital Management LLC lessened its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 26.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 396,022 shares of the company'sJanuary 15, 2024 | finance.yahoo.comAre You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great ChoiceJanuary 14, 2024 | finance.yahoo.comShareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years agoJanuary 11, 2024 | marketbeat.comInsider Selling: Organogenesis Holdings Inc. (NASDAQ:ORGO) Major Shareholder Sells 197,921 Shares of StockOrganogenesis Holdings Inc. (NASDAQ:ORGO - Get Free Report) major shareholder Albert Erani sold 197,921 shares of Organogenesis stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $4.37, for a total value of $864,914.77. Following the completion of the sale, the insider now directly owns 59,025,106 shares of the company's stock, valued at approximately $257,939,713.22. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.December 30, 2023 | benzinga.comOrganogenesis Hldgs Stock (NASDAQ:ORGO), Guidance and ForecastDecember 28, 2023 | finance.yahoo.comOrganogenesis (ORGO) is a Great Momentum Stock: Should You Buy?December 27, 2023 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Shares Gap Up Following Analyst UpgradeOrganogenesis (NASDAQ:ORGO) Shares Gap Up on Analyst UpgradeDecember 27, 2023 | marketbeat.comOrganogenesis (NASDAQ:ORGO) PT Raised to $6.00BTIG Research lifted their price target on Organogenesis from $4.00 to $6.00 and gave the company a "buy" rating in a report on Wednesday.December 18, 2023 | finance.yahoo.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For ExcitementDecember 7, 2023 | finance.yahoo.comOrganogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?November 30, 2023 | msn.comHere Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)November 27, 2023 | msn.comOrganogenesis Holdings Inc - (ORGO) Price Target Increased by 7.14% to 3.83November 24, 2023 | stocknews.com3 Biotech Stocks Flowing With Investment PotentialNovember 11, 2023 | finance.yahoo.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | msn.comDOCS, ORGO and GBIO are among pre market gainersNovember 10, 2023 | finance.yahoo.comThe recent US$46m market cap decrease is likely to have disappointed insiders invested in Organogenesis Holdings Inc. (NASDAQ:ORGO)November 9, 2023 | seekingalpha.comOrganogenesis Holdings Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 9, 2023 | markets.businessinsider.comOrganogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral. Stream the documentary for free by clicking here ORGO Media Mentions By Week ORGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGO News Sentiment▼0.430.76▲Average Medical News Sentiment ORGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGO Articles This Week▼21▲ORGO Articles Average Week Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MiMedx Group News Pacira BioSciences News Belite Bio News Kiniksa Pharmaceuticals News Akero Therapeutics News Spyre Therapeutics News ANI Pharmaceuticals News MannKind News AbCellera Biologics News Day One Biopharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss Ratings[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
